While previous studies have shown that mTOR inhibitors can cause interstitial pneumonitis, we also included COPD and pulmonary hypertension due to the theoretical risk that other pulmonary toxicity may be present. The gene discussed is MTOR; the disease is pulmonary arterial hypertension.